InsiderSignal.AI

InsiderSignal.ai

IMRX - Immuneering Corp

Insider Purchase by Feinberg Peter (Dir)

3 Months
After Trade
Before Trade

Loading data...

Trade Summary

1 month ago, Feinberg Peter, serving as Dir at Immuneering Corp (IMRX), purchased 20,000 shares at $4.35 per share, for a total transaction value of $86,904.00. Following this transaction, Feinberg Peter now holds 1,161,064 shares of IMRX.

This purchase represents a 2.00% increase in Feinberg Peter's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, January 12, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, January 14, 2026, 2 days after the trade was made.

Immuneering Corp operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Feinberg Peter

Feinberg Peter

Dir

Peter Feinberg is a Director at Immuneering Corp (NASDAQ:IMRX), a clinical-stage biopharmaceutical company focused on AI-driven drug discovery.[[1]](https://www.investing.com/news/insider-trading-news/immuneering-director-feinberg-buys-86k-in-shares-93CH-4447187)[[2]](https://www.marketbeat.com/instant-alerts/insider-buying-immuneering-nasdaqimrx-director-acquires-20000-shares-of-stock-2026-01-14/) On January 12, 2026, he purchased 20,000 shares of Class A Common Stock at a weighted average price of $4.3452, totaling $86,904, increasing his direct ownership to 156,766 shares.[[1]](https://www.investing.com/news/insider-trading-news/immuneering-director-feinberg-buys-86k-in-shares-93CH-4447187) He also holds significant indirect ownership through entities including PF Associates L.P. (392,242 shares), PEF LLC (476,615 shares), and S4K Investments LLC (135,441 shares).[[1]](https://www.investing.com/news/insider-trading-news/immuneering-director-feinberg-buys-86k-in-shares-93CH-4447187) Feinberg has a history of active investment in Immuneering, with multiple purchases over the past five years, including 25,000 shares on March 22, 2024, and no recorded sales, resulting in total ownership of approximately 1,141,064 shares valued at over $5 million as of recent filings.[[4]](https://www.gurufocus.com/insider/178418/peter-feinberg) Previously, he served as a director at Vascular Biogenics Ltd (VBLT).[[4]](https://www.gurufocus.com/insider/178418/peter-feinberg) His ongoing buys signal confidence in Immuneering amid the company's clinical advancements, such as promising Phase 2a data for pancreatic cancer treatment atebimetinib.[[1]](https://www.investing.com/news/insider-trading-news/immuneering-director-feinberg-buys-86k-in-shares-93CH-4447187)

View full insider profile →

Trade Price

$4.35

Quantity

20,000

Total Value

$86,904.00

Shares Owned

1,161,064

Trade Date

Monday, January 12, 2026

41 days ago

SEC Filing Date

Wednesday, January 14, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Immuneering Corp

Company Overview

No company information available
View news mentioning IMRX

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/3094799

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime